DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Sequest LV, Yang JC, Yamamoto N et al.
A phase III study of afatinib or cisplatin plus pemetrexed in patients with lung adenocarcinoma with EGFR mutations.
J Clin Oncol 2013; Jul 1. (Epub ahead of print)
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.